News and Announcements
Analytica FY16 Update; Successful $2.4m Capital Raise, R&D on PeriCoach® System, International Case Studies Published
- Published July 06, 2016 10:56AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Analytica has had a productive 2016, including a successful $2.4m capital raise with a cornerstone investment from Innov8 LLC, and the appointment of Dr. Thomas Lönngren to the Board. The company is driving R&D work on the PeriCoach® System, aiming to provide game-changing functionality by the end of 2016. Case studies have been published in the internationally-recognised Urological Nurses Journal describing PeriCoach’s benefits.
The company is pursuing over-the-counter regulatory clearance in the US, where it is currently prescription-only. Our AutoStart Burette product has also been authorised for use by Queensland Health for use in all public hospitals.
ABOUT ANALYTICA LTD
Analytica Limited (ASX:ALT) is an Australian medical device manufacturing and commercialisation company. Its lead product, the PeriCoach System, is a novel medical device to treat stress urinary incontinence (SUI) – a condition with significant unmet medical need and huge market potential.
PeriCoach is a medical device that measures the muscles that matter when treating stress urinary incontinence and increases pelvic muscle strength.